AAAAAA
Results: 26-42/42
Authors:
HOROWITZ R
SCHWARTZ EL
WADLER S
Citation: R. Horowitz et al., MODULATION OF 5-FLUOROURACIL BY INTERFERON - A REVIEW OF POTENTIAL CELLULAR TARGETS, Medical oncology, 12(1), 1995, pp. 3-8
Authors:
SCHWARTZ EL
GREVE DN
BONMASSAR G
Citation: El. Schwartz et al., SPACE-VARIANT ACTIVE VISION - DEFINITION, OVERVIEW AND EXAMPLES, Neural networks, 8(7-8), 1995, pp. 1297-1308
Authors:
WADLER S
SCHWARTZ EL
Citation: S. Wadler et El. Schwartz, CHEMOTHERAPY FOR COLORECTAL-CARCINOMA - OBSERVATIONS REGARDING RECENTCLINICAL-TRIALS USING BIOCHEMICAL MODULATION, Journal of clinical oncology, 13(10), 1995, pp. 2676-2677
Authors:
SCHWARTZ EL
BAPTISTE N
WADLER S
MAKOWER D
Citation: El. Schwartz et al., THYMIDINE PHOSPHORYLASE MEDIATES THE SENSITIVITY OF HUMAN COLON-CARCINOMA CELLS TO 5-FLUOROURACIL, The Journal of biological chemistry, 270(32), 1995, pp. 19073-19077
Authors:
SCHWARTZ EL
BAPTISTE N
MEGATI S
WADLER S
OTTER BA
Citation: El. Schwartz et al., 5-ETHOXY-2'-DEOXYURIDINE, A NOVEL SUBSTRATE FOR THYMIDINE PHOSPHORYLASE, POTENTIATES THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL WHEN USED IN COMBINATION WITH INTERFERON, AN INDUCER OF THYMIDINE PHOSPHORYLASE EXPRESSION, Cancer research, 55(16), 1995, pp. 3543-3550
Authors:
SCHWARTZ EL
HALLAM S
GALLAGHER RE
WIERNIK PH
Citation: El. Schwartz et al., INHIBITION OF ALL-TRANS-RETINOIC ACID METABOLISM BY FLUCONAZOLE IN-VITRO AND IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA, Biochemical pharmacology, 50(7), 1995, pp. 923-928
Authors:
BEDERSON BB
WALLACE RS
SCHWARTZ EL
Citation: Bb. Bederson et al., A MINIATURE PAN-TILT ACTUATOR - THE SPHERICAL POINTING MOTOR, IEEE transactions on robotics and automation, 10(3), 1994, pp. 298-308
Authors:
WALLACE RS
ONG PW
BEDERSON BB
SCHWARTZ EL
Citation: Rs. Wallace et al., SPACE-VARIANT IMAGE-PROCESSING, International journal of computer vision, 13(1), 1994, pp. 71-90
Authors:
ARAD N
SCHWARTZ EL
WOLLBERG Z
YESHURUN Y
Citation: N. Arad et al., ACOUSTIC BINAURAL CORRESPONDENCE USED FOR LOCALIZATION OF NATURAL ACOUSTIC-SIGNALS, Neural networks, 7(3), 1994, pp. 441-447
Authors:
WADLER S
SCHWARTZ EL
Citation: S. Wadler et El. Schwartz, BIOLOGIC AGENTS AS BIOCHEMICAL MODULATORS - PHARMACOLOGICAL BASIS FORTHE INTERACTION OF CYTOTOXIC CHEMOTHERAPEUTIC DRUGS AND INTERFERON, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 21-30
Authors:
SCHWARTZ EL
BAPTISTE N
OCONNOR CJ
WADLER S
OTTER BA
Citation: El. Schwartz et al., POTENTIATION OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL IN COLON-CARCINOMA CELLS BY THE COMBINATION OF INTERFERON AND DEOXYRIBONUCLEOSIDESRESULTS FROM COMPLEMENTARY EFFECTS ON THYMIDINE PHOSPHORYLASE, Cancer research, 54(6), 1994, pp. 1472-1478
Authors:
SPARANO JA
WADLER S
DIASIO RB
ZHANG RW
LU ZH
SCHWARTZ EL
EINZIG A
WIERNIK PH
Citation: Ja. Sparano et al., PHASE-I TRIAL OF LOW-DOSE, PROLONGED CONTINUOUS-INFUSION FLUOROURACILPLUS INTERFERON-ALFA - EVIDENCE FOR ENHANCED FLUOROURACIL TOXICITY WITHOUT PHARMACOKINETIC PERTURBATION, Journal of clinical oncology, 11(8), 1993, pp. 1609-1617
Authors:
RUPPIN E
SCHWARTZ EL
YESHURUN Y
Citation: E. Ruppin et al., EXAMINING THE VOLUME EFFICIENCY OF THE CORTICAL ARCHITECTURE IN A MULTIPROCESSOR NETWORK MODEL, Biological cybernetics, 70(1), 1993, pp. 89-94
Authors:
SPARANO JA
WADLER S
SCHWARTZ EL
DIASIO R
Citation: Ja. Sparano et al., CLINICAL AND PHARMACOLOGICAL STUDIES OF INTERFERON AND CHEMOTHERAPY IN GASTROINTESTINAL AND BREAST-CANCER, International journal of clinical pharmacology research, 13(1), 1993, pp. 1-9
Authors:
MAZUREK C
DUTCHER JP
SCHWARTZ EL
GARL S
BENSON L
WIERNIK PH
Citation: C. Mazurek et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MENOGARIL (7-CON-O-METHYLNOGAROL) IN PREVIOUSLY TREATED PATIENTS WITH ACUTE-LEUKEMIA, Investigational new drugs, 11(4), 1993, pp. 313-322
Authors:
WADLER S
MAO X
BAJAJ R
HALLAM S
SCHWARTZ EL
Citation: S. Wadler et al., N-(PHOSPHONACETYL)-L-ASPARTATE SYNERGISTICALLY ENHANCES THE CYTOTOXICITY OF 5-FLUOROURACIL INTERFERON-ALPHA-2A AGAINST HUMAN COLON-CANCER CELL-LINES, Molecular pharmacology, 44(5), 1993, pp. 1070-1076
Authors:
SPARANO JA
WADLER S
LIEBES L
ROBERT NJ
SCHWARTZ EL
DUTCHER JP
Citation: Ja. Sparano et al., PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER, Cancer research, 53(15), 1993, pp. 3509-3512